Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Fuji
Baxter
Cerilliant
Express Scripts
Daiichi Sankyo
QuintilesIMS
Colorcon
US Department of Justice
AstraZeneca

Generated: May 20, 2018

DrugPatentWatch Database Preview

Antazoline phosphate; naphazoline hydrochloride - Generic Drug Details

or, see our see our flat-rate plans

« Back to Dashboard

What are the generic drug sources for antazoline phosphate; naphazoline hydrochloride and what is the scope of antazoline phosphate; naphazoline hydrochloride patent protection?

Antazoline phosphate; naphazoline hydrochloride
is the generic ingredient in one branded drug marketed by Novartis and is included in one NDA. Additional information is available in the individual branded drug profile pages.

Summary for antazoline phosphate; naphazoline hydrochloride
US Patents:0
Tradenames:1
Applicants:1
NDAs:1
Clinical Trials: 811
DailyMed Link:antazoline phosphate; naphazoline hydrochloride at DailyMed

US Patents and Regulatory Information for antazoline phosphate; naphazoline hydrochloride

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Novartis VASOCON-A antazoline phosphate; naphazoline hydrochloride SOLUTION/DROPS;OPHTHALMIC 018746-002 Jul 11, 1994 DISCN No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

or, see our see our flat-rate plans

or, see our see our flat-rate plans

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Harvard Business School
Express Scripts
Queensland Health
Johnson and Johnson
Baxter
Federal Trade Commission
Cipla
Boehringer Ingelheim
US Army

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.